Hussam H Shaheen

Title: Innovations of Hussam H Shaheen in Antibody Development

Introduction

Hussam H Shaheen is an accomplished inventor based in Waltham, MA (US). He has made significant contributions to the field of biotechnology, particularly in the development of antibodies that target interleukin 13 (IL-13). His work has implications for treating various inflammatory diseases.

Latest Patents

Hussam H Shaheen holds a patent for "Antibodies that bind interleukin 13 and methods of use." This patent describes novel and improved antibodies that bind IL-13 and outlines methods for inhibiting its biological activity. The patent also details pharmaceutical compositions that include these anti-IL-13 antibodies, which can be utilized in the treatment of inflammatory diseases associated with elevated levels of IL-13 and/or IgE. He has 1 patent to his name.

Career Highlights

Hussam H Shaheen is currently associated with Apogee Therapeutics, Inc., where he continues to innovate in the field of therapeutic antibodies. His research focuses on the mechanisms of IL-13 and its role in various diseases, contributing to advancements in medical treatments.

Collaborations

Hussam has collaborated with notable colleagues, including Kenneth Evan Thompson and Peter Harwin. These partnerships have fostered a collaborative environment that enhances the research and development of new therapeutic solutions.

Conclusion

Hussam H Shaheen's work in developing antibodies against interleukin 13 represents a significant advancement in biotechnology. His contributions are paving the way for new treatments for inflammatory diseases, showcasing the importance of innovation in the medical field.